ArticleThe Journal of pharmacology and experimental therapeutics2026
Striatal remodeling in Parkinson disease.
Soren D Emerson, Chiho Sugimoto, Sarah C Honeycutt, Erin S Calipari
Abstract read
In one paragraphArticle in The Journal of pharmacology and experimental therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
4 authors.
Soren D EmersonVanderbilt Brain Institute, Vanderbilt University, Nashville, Tennessee; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee; Vanderbilt Center for Addiction Research, Vanderbilt University, Nashville, Tennessee.
Chiho SugimotoDepartment of Pharmacology, Vanderbilt University, Nashville, Tennessee; Vanderbilt Center for Addiction Research, Vanderbilt University, Nashville, Tennessee.
Sarah C HoneycuttDepartment of Pharmacology, Vanderbilt University, Nashville, Tennessee; Vanderbilt Center for Addiction Research, Vanderbilt University, Nashville, Tennessee.
Erin S CalipariVanderbilt Brain Institute, Vanderbilt University, Nashville, Tennessee; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee; Vanderbilt Center for Addiction Research, Vanderbilt University, Nashville, Tennessee; Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee; Department of Psychiatry and Behavioral Sciences, Vanderbilt University, Nashville, Tennessee. Electronic address: erin.calipari@vanderbilt.edu.
Funding
Making and breaking opioid memories to prevent relapseDP1DA048931 · NIDA · VANDERBILT UNIVERSITY · PI CALIPARI, ERIN · 2019 to 2023
$2.4MMolecular determinants of ensemble recruitment by drugs of abuseR01DA062024 · NIDA · VANDERBILT UNIVERSITY · PI Erin Calipari · 2025 to 2026
$2.3MDefining the Role of D1 and D2 Medium Spiny Neurons in Relapse to Cocaine SeekingR00DA042111 · NIDA · VANDERBILT UNIVERSITY · PI CALIPARI, ERIN · 2018 to 2020
$747kDefining the cell-type specific role of histone acetyltransferase KAT2a in nucleus accumbens D1 medium spiny neurons as a driver of cocaine use disorderF31DA058450 · NIDA · VANDERBILT UNIVERSITY · PI Soren D Emerson · 2023 to 2026
$147kNIDA NIH HHS DP1 DA048931NIDA NIH HHS F31 DA058450NIDA NIH HHS R00 DA042111NIDA NIH HHS R01 DA062024
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Dopamine D1 receptorDopamine D2 receptorGPCR signalingParkinson diseaseSpinophilinStriatum
Identifiers
PMID42401195
PMCPMC13494218
What Socratic holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390